tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
BBIO is currently covered by 19 analysts with an average price target of $102.72. This is a potential upside of $34.16 (49.82%) from yesterday's end of day stock price of $68.56.
BridgeBio Pharma's activity chart (see below) currently has 311 price targets and 295 ratings on display. The stock rating distribution of BBIO is 95.59% BUY and 4.41% HOLD.
Analysts average stock forecasts to be materialized ratio is 76.4% with an average time for these price targets to be met of 230.96 days.
Highest price target for BBIO is $156, Lowest price target is $80, average price target is $102.72.
Most recent stock forecast was given by SEAN LAAMAN from MORGAN STANLEY. First documented stock forecast 22-Jul-2019.
Currently out of the existing stock ratings of BBIO, 65 are a BUY (95.59%), 3 are a HOLD (4.41%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Jan-2026
$87
$18.44 (26.90%)
$97
Hold Since 19-May-2026
$91
$22.44 (32.73%)
$93
Buy Since 04-Sep-2024
$120
$51.44 (75.03%)
$115
Buy Since 20-May-2021
$156
$87.44 (127.54%)
$157
18 days ago
(07-Oct-2026)
10/12 (83.33%)
$89.5 (134.59%)
443
Buy Since 13-Apr-2020
$120
$51.44 (75.03%)
$120
1 months 15 days ago
(10-Sep-2026)
35/43 (81.4%)
$47.5 (65.52%)
348
What is BBIO (BridgeBio Pharma) average time for price targets to be met?
Which analyst most recently updated their price target on BBIO (BridgeBio Pharma)?
Which analyst has the most public recommendations on BBIO (BridgeBio Pharma)?
Which analyst is the currently most bullish on BBIO (BridgeBio Pharma)?
Which analyst is the currently most reserved on BBIO (BridgeBio Pharma)?
